FDA Approves METHADONE HYDROCHLORIDE — VistaPharm, LLC

VistaPharm, LLC has earned regulatory approval to manufacture and market its ANDA for the generic version of methadone hydrochloride, a move poised to expand generic market access for this opioid therapy. This authorization underscores the sustained commercial viability of the methadone ecosystem and adds volume to the opioid market, potentially intensifying price competition.